A Randomized, Double-Blind, Placebo-Controlled, 52-Week Study of the Efficacy and Safety of Belimumab Administered Subcutaneously Plus Standard Care to Patients with Systemic Lupus Erythematosus (SLE)

被引：0
|
作者：
Stohl, William [1 ]
Schwarting, Andreas [2 ]
Okada, Masato [3 ]
Scheinberg, Morton [4 ]
Doria, Andrea [5 ]
Hammer, Anne [6 ]
Kleoudis, Christi [7 ]
Bass, Damon [8 ]
Groark, James [9 ]
Fox, Norma Lynn [10 ]
Roth, David [11 ]
Gordon, David [11 ]
机构：
[1] Univ So Calif, Keck Sch Med, Div Rheumatol, Los Angeles, CA 90033 USA
[2] ACURA Kliniken, Bad Kreuznach, Germany
[3] St Lukes Int Hosp, Immunorheumatol Ctr, Tokyo, Japan
[4] Rheumatol Hosp Abreu Sodre Pesquisa Clin, Sao Paulo, Brazil
[5] Univ Padua, Div Rheumatol, Padua, Italy
[6] GlaxoSmithKline, Res Triangle Pk, NC USA
[7] Parexel, Durham, NC USA
[8] GlaxoSmithKline, Immunoinflammat, King Of Prussia, PA USA
[9] GlaxoSmithKline, Philadelphia, NC USA
[10] GlaxoSmithKline, Washington, MD USA
[11] GlaxoSmithKline, Philadelphia, PA USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2015年 / 67卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3218
引用
收藏
页数：2
相关论文
共 50 条
  • [11] Double-blind, randomized, placebo-controlled pilot study of leflunomide in systemic lupus erythematosus
    Tam, LS
    Li, EK
    Wong, CK
    Lam, CWK
    Szeto, CC
    LUPUS, 2004, 13 (08) : 601 - 604
  • [12] Bromocriptine in systemic lupus erythematosus: A double-blind, randomized placebo-controlled study.
    AlvarezNemegyei, J
    CovarrubiasCobos, A
    EscalanteTriay, F
    SosaMunoz, G
    Jara, LJ
    ARTHRITIS AND RHEUMATISM, 1996, 39 (09): : 1351 - 1351
  • [13] Year-3 Observational Follow-up of Belimumab Safety (Mortality and Malignancies) in Patients with SLE Who Completed a Phase 4, 52-Week, Randomized, Double-Blind Placebo-Controlled Safety Study
    Sheikh, Saira
    Wei, Cheng-Chung
    Tegzova, Dana
    Stohl, William
    de Toledo, Ricardo Acayaba
    Mucenic, Tamara
    Banfi, Mauricio Abello
    Maksimowicz-McKinnon, Kathleen
    Abud-Mendoza, Carlos
    Navarra, Sandra
    Garcia, Mercedes
    Garcia-De La Torre, Ignacio
    Kurrasch, Regina
    Fernandes, Sofia
    Harris, Julia
    Muzaffar, Saima
    Fox, Norma Lynn
    Liu, Andrew
    Quasny, Holly
    Roth, David
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 2696 - 2699
  • [14] Pneumococcal Vaccination in Patients with Systemic Lupus Erythematosus: A Multicenter Placebo-Controlled Randomized Double-Blind Study
    Grabar, Sophie
    Groh, Matthieu
    Bahuaud, Mathilde
    Costedoat-Chalumeau, Nathalie
    Le Guern, Veronique
    Fior, Renato
    Bienvenu, Boris
    Hachulla, Eric
    Hamidou, Mohamed
    Sibilia, Jean
    Mathian, Alexis
    Hanslik, Thomas
    Guillevin, Loic
    Batteux, Frederic
    Launay, Odile
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [15] Pneumococcal vaccination in patients with systemic lupus erythematosus: A multicenter placebo-controlled randomized double-blind study
    Grabar, Sophie
    Groh, Matthieu
    Bahuaud, Mathilde
    Le Guern, Veronique
    Costedoat-Chalumeau, Nathalie
    Mathian, Alexis
    Hanslik, Thomas
    Guillevin, Loic
    Batteux, Frederic
    Launay, Odile
    VACCINE, 2017, 35 (37) : 4877 - 4885
  • [16] Memantine in Systemic Lupus Erythematosus: A Randomized, Double-Blind Placebo-Controlled Trial
    Petri, Michelle
    Naqibuddin, Mohammad
    Sampedro, Margaret
    Omdal, Roald
    Carson, Kathryn A.
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2011, 41 (02) : 194 - 202
  • [17] Belimumab after B cell depletion therapy in patients with systemic lupus erythematosus (BEAT Lupus) protocol: a prospective multicentre, double-blind, randomised, placebo-controlled, 52-week phase II clinical trial
    Jones, Alexis
    Muller, Patrick
    Dore, Caroline J.
    Ikeji, Felicia
    Caverly, Emilia
    Chowdhury, Kashfia
    Isenberg, David A.
    Gordon, Caroline
    Ehrenstein, Michael R.
    BMJ OPEN, 2019, 9 (12):
  • [18] Botulinum toxin type A in the treatment of primary axillary hyperhidrosis: A 52-week multicenter double-blind, randomized, placebo-controlled study of efficacy and safety
    Lowe, Nicholas J.
    Glaser, Dee Anna
    Eadie, Nina
    Daggett, Simon
    Kowalski, Jonathan W.
    Lai, Pan-Yu
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 56 (04) : 604 - 611
  • [19] Safety and efficacy of metformin in systemic lupus erythematosus: a multicentre, randomised, double-blind, placebo-controlled trial
    Sun, Fangfang
    Wang, Hui Jing
    Liu, Zhe
    Geng, Shikai
    Wang, Haiting
    Wang, Xiaodong
    Li, Ting
    Morel, Laurence
    Wan, Weiguo
    Lu, Liangjing
    Teng, Xiangyu
    Ye, Shuang
    LANCET RHEUMATOLOGY, 2020, 2 (04): : E210 - E216
  • [20] A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Sibeprenlimab Administered Subcutaneously in Patients With IgA Nephropathy
    Rizk, Dana
    Perkovic, Vlado
    Lafayette, Richard A.
    Trimarchi, Hernan
    Barratt, Jonathan
    Carroll, Kevin
    Tesar, Vladimir
    Zhang, Hong
    Suzuki, Yusuke
    Liew, Adrian
    Wong, Muh Geot
    Leslie, Bruce R.
    Mathur, Mohit
    Hafkin, Jeffrey
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 799 - 799
12345